Patrick J Heron's Net Worth

$804 Million

Estimate Recalculated Feb 22, 2024 05:22PM EST

Who is Patrick J Heron?

Patrick J Heron has an estimated net worth of $804 Million. This is based on reported shares across multiple companies, which include Vaxcyte, Inc., Trubion Pharmaceuticals, Inc, Tarsus Pharmaceuticals, Inc., GLAUKOS Corp, ALPINE IMMUNE SCIENCES, INC., COLLEGIUM PHARMACEUTICAL, INC, Phathom Pharmaceuticals, Inc., Arcutis Biotherapeutics, Inc., ANAPTYSBIO INC, Imago BioSciences, Inc., Sierra Oncology, Inc., Mirum Pharmaceuticals, Inc., Frazier Lifesciences Acquisition Corp, Cidara Therapeutics, Inc., Entasis Therapeutics Holdings Inc., Iterum Therapeutics plc, Passage BIO, Inc., Aptinyx Inc., HilleVax, Inc., and Regado Biosciences Inc.

SEC CIK

Patrick J Heron's CIK is 0001365617

Past Insider Trading and Trends

2020 was Patrick J Heron's most active year for acquiring shares with 26 total transactions. Patrick J Heron's most active month to acquire stocks was the month of April. 2018 was Patrick J Heron's most active year for disposing of shares, totalling 14 transactions. Patrick J Heron's most active month to dispose stocks was the month of September. 2022 saw Patrick J Heron paying a total of $73,012,773.50 for 4,921,713 shares, this is the most they've acquired in one year. In 2020 Patrick J Heron cashed out on 19,166,894 shares for a total of $250,010.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Tarsus Pharmaceuticals, Inc. (TARS) Snapshot price: $27.52

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
1.92M
$16.00
1.92M
Oct 20
Form 3
0
0
No matching records found

GLAUKOS Corp (GKOS) Snapshot price: $94.635

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
2.6M
2.6M
Jun 30
Form 4
0
0
Jun 26
Form 3
0
0
No matching records found

Phathom Pharmaceuticals, Inc. (PHAT) Snapshot price: $7.09

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-20.00%
-1.46M
5.83M
Jun 12
Form 4
+49.33%
2.41M
$16.86
$40,575,317.00
7.28M
Oct 29
Form 3
0
0
No matching records found

Frazier Lifesciences Acquisition Corp No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3/A
0
0
Form 4
1.5M
$10.00
$15,010,000.00
1.5M
Dec 11
Form 3
0
0
No matching records found

Arcutis Biotherapeutics, Inc. (ARQT) Snapshot price: $5.735

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+0.92%
80K
$2.50
$200,000.00
8.76M
Oct 24
Form 4
+101.46%
4.38K
8.69K
May 31
Form 4
+2.96%
250K
$20.00
$5,000,000.00
8.68M
Aug 5
Form 4
4.31K
4.31K
Jun 1
Form 4
0
0
Jun 9
Form 4
-20.00%
-2.11M
8.43M
May 10
Form 4
0
0
Feb 27
Form 4
+1,971.14%
10.03M
$17.00
10.54M
Feb 4
Form 3
0
0
No matching records found